Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orbix Medical developed minimally invasive, CE-marked implantable devices—OrbiShape and OrbiSymm—for use in aesthetic breast surgeries such as mastopexy, reduction, and symmetrisation. Clinical experience reported superior long-term results compared to traditional techniques, with reduced risk of recurrent ptosis. The products have been used successfully in Europe with more than six years' follow-up on initial procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orbix Medical.